ID: ALA2146587

Max Phase: Preclinical

Molecular Formula: C18H13FN2O

Molecular Weight: 292.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cn1c(-c2cc(-c3ccc(F)cc3)no2)cc2ccccc21

Standard InChI:  InChI=1S/C18H13FN2O/c1-21-16-5-3-2-4-13(16)10-17(21)18-11-15(20-22-18)12-6-8-14(19)9-7-12/h2-11H,1H3

Standard InChI Key:  HFQCTCKEBWBCCH-UHFFFAOYSA-N

Associated Targets(Human)

Calu-3 339 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 292.31Molecular Weight (Monoisotopic): 292.1012AlogP: 4.64#Rotatable Bonds: 2
Polar Surface Area: 30.96Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.25CX LogP: 4.32CX LogD: 4.32
Aromatic Rings: 4Heavy Atoms: 22QED Weighted: 0.54Np Likeness Score: -1.45

References

1. Md Tohid SF, Ziedan NI, Stefanelli F, Fogli S, Westwell AD..  (2012)  Synthesis and evaluation of indole-containing 3,5-diarylisoxazoles as potential pro-apoptotic antitumour agents.,  56  [PMID:22955095] [10.1016/j.ejmech.2012.08.009]

Source